Daily Intelligence Brief
Depo-Provera and Social Media Addiction Filings Lead Active Mass-Tort Docket
Reproductive health and digital safety claims dominated the federal mass-tort landscape yesterday, fueled by a dense wave of new filings. The surge was led by the Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation (MDL 3140), which logged 44 new complaints as firms like Wright & Schulte LLC and Anapol Weiss targeted the contraceptive shot's alleged link to brain tumors. In the digital sector, tech platforms faced mounting pressure as the Social Media Adolescent Addiction Personal Injury Products Liability Litigation (MDL 3047) added 14 new actions, driven by a dozen filings from Wright & Schulte LLC and support from Clancy Fleishman LLP. Meanwhile, cosmetic safety concerns continued to drive volume, with 13 new cases filed in the Johnson & Johnson Talcum Powder Products Marketing, Sales Practices and Products Liability Litigation (MDL 2738)—led by The Miller Firm LLC and OnderLaw LLC—and 9 complaints added to the Hair Relaxer Marketing, Sales Practices, and Products Liability Litigation (MDL 3060) by firms including Johnson Law Group and Gori Law Firm PC. Finally, the Uber Technologies, Inc., Passenger Sexual Assault Litigation (MDL 3084) expanded by 6 filings, with Peiffer Wolf and Anapol Weiss leading the effort to hold the rideshare giant accountable for rider safety. See the full filing feed and firm-level breakdowns here.
Sports Betting Platforms Face Growing Wave of Additive Design Lawsuits
On June 10, 2026, legal pressure on the mobile gambling industry intensified as new consumer protection lawsuits targeted major sports wagering platforms, including DraftKings. The complaints allege that these apps utilize deceptive promotions and addictive push notifications designed to hook vulnerable users and exploit those struggling with gambling addiction. Plaintiffs' attorneys are modeling their claims on product liability theories, arguing that the platforms' predatory design features constitute a defective product that causes severe psychological and financial harm. The litigation seeks injunctive relief to compel platform reform, alongside substantial compensatory damages for affected users. As filings continue to mount across multiple jurisdictions, legal analysts expect plaintiffs to petition for coordinated pretrial proceedings in the near future.
North Carolina Sues Chemical Manufacturer Over 1,4-Dioxane Water Pollution
On June 10, 2026, the state of North Carolina filed a major environmental lawsuit against a chemical manufacturer for allegedly polluting a local creek with 1,4-dioxane. The state's complaint accuses the company of discharging high concentrations of the synthetic industrial solvent, a probable human carcinogen, into a tributary of the Cape Fear River basin. State officials are seeking injunctive relief to compel the company to cease all unpermitted discharges and implement advanced filtration technology, alongside substantial civil penalties for the environmental damage. Regulators emphasize that the contamination threatens municipal drinking water systems that serve hundreds of thousands of residents downstream. This action underscores North Carolina's aggressive push to enforce state environmental standards and address persistent chemical pollution in its public waterways.
Generated by LexGenius Feed. Signals sourced from PACER federal court dockets, FDA/OpenFDA adverse event database, Federal Register, PubMed, and Google News.